Logo
x

Search

Subscribe Now

receives

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

  • October 25, 2021
Pfizer's Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC's Advisory Committee Recommendation for Invasive Disease and Pneumonia

Pfizer's Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC's Advisory Committee Recommendation for Invasive D...

  • October 21, 2021
Gilead's Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA's Approval for Expanded Indication to Treat HIV-1

Gilead's Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA's Approval for Expanded In...

  • October 19, 2021
Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma

Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma

  • October 19, 2021
Genentech's Tecentriq Receives the US FDA's Approval as Adjuvant Treatment for Early Non-Small Cell Lung Cancer

Genentech's Tecentriq Receives the US FDA's Approval as Adjuvant Treatment for Early Non-Small Cell Lung Cancer

  • October 18, 2021
AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the EU

AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the...

  • October 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.